Factors | N (%) |
---|---|
Gender | |
Male | 81 (93.1) |
Female | 6 (6.9) |
Age (years) | |
< 70 | 57 (65.5) |
≥ 70 | 30 (34.5) |
Pathological types | |
NSCLC | 57 (65.5) |
Adenocarcinoma | 17 (19.5) |
Squamous cell carcinoma | 24 (27.6) |
Large cell carcinoma | 1 (1.1) |
Unclassified NSCLC | 15 (17.2) |
SCLC | 30 (34.5) |
Tumor stage | |
I | 2 (2.3) |
IIIA | 24 (27.6) |
IIIB | 37 (42.5) |
IIIC | 3 (3.4) |
IV | 10 (11.5) |
Postoperative | 11 (12.6) |
Chemotherapy | |
Concurrent | 19 (21.8) |
Sequential | 68 (78.2) |